Deferiprone - Open Access .click

Results 121 to 130 of about 10,843 (242)

Deferiprone-induced arthropathy in thalassemia: MRI findings in a case [PDF]

, 2009
Gyan Chand +3 more
openalex +1 more source

Congenital dyserythropoietic anemia type I with bone abnormalities, mutations of the CDAN I gene, and significant responsiveness to alpha-interferon therapy [PDF]

, 2018
Congenital dyserythropoietic anemia type I (CDA I) is a rare autosomal recessive disorder with ineffective erythropoiesis, characteristic morphological abnormalities of erythroblasts, and iron overloading. CDA I is caused by mutations in the CDAN I gene,
Benz, Rudolf +4 more
core

Deferiprone modulates in vitro responses by peripheral blood T cells from control and relapsing–remitting multiple sclerosis subjects [PDF]

, 2011
Matthew E. Sweeney +6 more
openalex +1 more source

Effectiveness of deferiprone in transfusion‐independent beta‐thalassemia/HbE patients [PDF]

, 2011
Krittapoom Akrawinthawong +3 more
openalex +1 more source

Pharmacological treatments for Friedreich ataxia [PDF]

, 2016
BACKGROUND: Friedreich ataxia is a rare inherited autosomal recessive neurological disorder, characterised initially by unsteadiness in standing and walking, slowly progressing to wheelchair dependency usually in the late teens or early twenties.
Brassington, R +4 more
core

A national register for surveillance of inherited disorders: beta thalassaemia in the United Kingdom [PDF]

, 2001
OBJECTIVE: To demonstrate the value of a national register for surveillance of services for an inherited disorder. METHODS: Data from the United Kingdom Thalassaemia Register and the United Kingdom Register of Prenatal Diagnosis for Haemoglobin Disorders
Darlison, M +7 more
core +1 more source

Deferiprone Reduces Amyloid-β and Tau Phosphorylation Levels but not Reactive Oxygen Species Generation in Hippocampus of Rabbits Fed a Cholesterol-Enriched Diet [PDF]